BIOGEN INC. is 3.9x more valuable than REPLIGEN CORP by market capitalization ($28.68 B vs $7.38 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RGEN | BIIB |
|---|---|---|
| Market cap | $7.38 B | $28.68 B |
| US-listed rank | #1115 | #476 |
| Revenue (latest FY) | $141.24M | $9.89B |
| Net income (latest FY) | $48.89M | $1.29B |
| Net margin | 34.6% | 13.1% |
| P/E (trailing FY) | 150.9 | 22.2 |
| SEC filings | 1,331 | 2,690 |
BIOGEN INC. is 3.9x more valuable than REPLIGEN CORP by market capitalization ($28.68 B vs $7.38 B).
In their latest fiscal years, REPLIGEN CORP reported $141.24M in revenue while BIOGEN INC. reported $9.89B.
Full pages: REPLIGEN CORP and BIOGEN INC., or browse the full rankings.